Skip to main content

Behavioral Manifestations of Alzheimer’s Disease

  • Conference paper
Contemporary Neuropsychiatry
  • 234 Accesses

Summary

Neuropsychiatric manifestations are common in Alzheimer’s disease (AD). Nearly all patients eventually exhibit some form of behavioral change. The Neuropsychiatric Inventory (NPI) is a valid and reliable means of assessing behavioral alterations in patients with AD and other dementias. The NPI assesses ten common types of behavioral changes evident in AD and has a caregiver distress scale allowing assessment of the amount of distress engendered by each of the behavioral changes. Investigations using the NPI and neuroimaging have demonstrated correlations between apathy and diminished medial frontal perfusion and psychosis and disproportionately reduced perfusion of left medial orbital frontal, left anterior cingulate, left and right dorsolateral frontal, left dorsal lateral parietal, left pulmonar, left ventral striatum, and left cerebellum. High scores on the dysphoria subscale of the NPI correlate with reduced metabolism in the left and right superior frontal gyrus, middle frontal gyrus, inferior frontal gyrus, and anterior cingulate gyrus. The NPI also allows assessment of the response of behaviors to psychopharmacological interventions. Reductions in behavioral pathology have been demonstrated with cholinesterase inhibitors (tacrine, donepezil, metrifonate, galantamine, and rivastigmine) as well as antipsychotic agents (olanzapine).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  2. Cummings JL, Mega M, Gray K, et al (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314

    Article  PubMed  CAS  Google Scholar 

  3. Wood S, Cummings JL, Hsu M-A, et al (2000) The use of the Neuropsychiatric Inventory in nursing home residents. Am J Geriatr Psychiatry 8:75–83

    Article  PubMed  CAS  Google Scholar 

  4. Mega M, Cummings JL, Fiorello T, Gombein J (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology 46:130–135

    Article  PubMed  CAS  Google Scholar 

  5. Frisoni GB, Rozzini L, Gozzetti A, et al (1999) Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 10:130–138

    Article  PubMed  CAS  Google Scholar 

  6. Kaufer D, Cummings JL, Christine D (1998) Differential neuropsychiatric symptom responses to tacrine in Alzheimer’s disease: relationship to dementia severity. J Neuropsychol Clin Neurosci 10:55–63

    CAS  Google Scholar 

  7. Craig AH, Cummings JL, Fairbanks LEA (1996) Cerebral blood flow correlates of apathy in Alzheimer’s disease. Arch Neurol 53:1116–1120

    Article  PubMed  CAS  Google Scholar 

  8. Mega MS, Lee L, Dinov ID, et al (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry (in press)

    Google Scholar 

  9. Hirono N, Mori E, Ishii K, et al (1998) Frontal lobe hypometabolism and depression in Alzheimer’s disease. Neurology 50:380–383

    Article  PubMed  CAS  Google Scholar 

  10. Levy ML, Cummings JL, Kahn-Rose R (1999) Neuropsychiatric symptoms and cholinergic therapy for Alzheimer’s disease. Gerontology 45 (suppl1):15–22

    Article  PubMed  CAS  Google Scholar 

  11. Kaufer DI, Cummings JL, Christine D, et al (1998) Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: The Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 46:210–215

    PubMed  CAS  Google Scholar 

  12. Morris JC, Cyrus PA, Orazem J, et al (1998) Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer’s disease. Neurology 50:1222–1230

    Article  PubMed  CAS  Google Scholar 

  13. Street J, Clark WS, Mitan S, et al (1998) Olanzapine in the treatment of psychosis and behavioral disturbances associated with Alzheimer’s disease. American College of Neuropsychopharmacology annual meeting. American College of Neuropsychopharmacology, Las Croabas, Puerto Rico

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Japan

About this paper

Cite this paper

Cummings, J.L. (2001). Behavioral Manifestations of Alzheimer’s Disease. In: Miyoshi, K., Shapiro, C.M., Gaviria, M., Morita, Y. (eds) Contemporary Neuropsychiatry. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67897-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-67897-7_12

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-67992-9

  • Online ISBN: 978-4-431-67897-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics